Oligo Trend

Executive Summary

Oligo Trend, LLC is a San Diego-based company founded in 2011 that specializes in designing, synthesizing, and validating oligonucleotide primers and probes for real-time PCR assays targeting infectious diseases. Its portfolio includes panels for viruses, bacteria, fungi, and parasites, and it has processed over 300,000 clinical tests since 2017, including COVID-19 RT-PCR. The company’s long-standing experience in assay development positions it as a reliable partner for diagnostics in both clinical and public health settings. Despite being privately held with limited disclosed funding, Oligo Trend has demonstrated operational resilience and technical capability through a decade of service.

Upcoming Catalysts (preview)

• Q3 2026Launch of expanded respiratory panel covering emerging variants70% success
• Q4 2026Partnership with a major hospital network or diagnostic lab50% success
• Q1 2027FDA 510(k) clearance for a new multiplex pathogen test40% success